4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-065618
EVP, Research & CSO sold 1,375 shares at $32.67 ($44,921)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-11-16 | Option exercise | +1,375 | $1.53 | $2,104 | 109,075 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2021-11-16 | Sale | −1,375 | $32.67 | $44,921 | 107,700 | D: show line 2 in the form |
| Open-market sales · 1,375 sh · avg $32.67 · $44,921 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-11-16 | Option exercise · Stock Option (Right to Buy) | −1,375 | 245,630 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…